MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$227M | $56M | $10M | −$71M | −$120M | −$133M | −$89M | −$39M |
| Capital expenditures | $1.5M | $954K | $993K | $109K | $278K | $24K | $225K | $281K |
| Free cash flow | −$229M | $55M | $9.3M | −$71M | −$120M | −$133M | −$89M | −$40M |
| Stock-based compensation | $104M | $71M | $48M | $35M | $27M | $23M | $13M | $6.1M |
| Free cash flow margin | −37.0% | 10.5% | 2.8% | −38.1% | −156.3% | −693.8% | — | — |